| QSMLX | VRTIX | QSMLX / VRTIX | |
| Total Expense Ratio | 0.61 | 0.07 | 871% |
| Annual Report Gross Expense Ratio | 0.74 | 0.07 | 1,057% |
| Fund Existence | 13 years | 15 years | - |
| Gain YTD | 9.102 | 14.503 | 63% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 5000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 142M | 14.3B | 1% |
| Annual Yield % from dividends | 1.34 | 1.17 | 114% |
| Returns for 1 year | 6.78 | 13.07 | 52% |
| Returns for 3 years | 27.16 | 46.54 | 58% |
| Returns for 5 years | 22.99 | 29.26 | 79% |
| Returns for 10 years | 57.57 | 130.53 | 44% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ELIL | 28.43 | 0.36 | +1.28% |
| Direxion Daily LLY Bull 2X Shares | |||
| AVMA | 66.80 | 0.21 | +0.32% |
| Avantis Moderate Allocation ETF | |||
| DINT | 28.88 | 0.07 | +0.25% |
| Davis Select International ETF | |||
| HYTI | 19.76 | 0.03 | +0.18% |
| FT Vest High Yield & Target Income ETF | |||
| ARKG | 30.18 | 0.04 | +0.13% |
| ARK Genomic Revolution ETF | |||